Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04877379 | VNRX-7145 Drug-Drug Interaction in Healthy Adult Volunteers | ||
| NCT01397929 | An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors | ||
| NCT00965042 | Effect of Ceftobiprole on Human Intestinal Microflora | ||
| NCT04045613 | Derazantinib and Atezolizumab in Patients With Urothelial Cancer | ||
| NCT03138733 | Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia | ||
| NCT00770978 | Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU | ||
| NCT01030731 | Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease | ||
| NCT01731353 | FungiScope - A Global Emerging Fungal Infection Registry | ||
| NCT00124475 | Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis | ||
| NCT04240886 | Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds | ||
| NCT03137173 | Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections | ||
| NCT00771524 | Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone | ||
| NCT06961708 | A Study of Fosmanogepix in Healthy Adult Chinese Subjects | ||
| NCT04804059 | A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males | ||
| NCT01884558 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin | ||
| NCT01657838 | Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects | ||
| NCT05491733 | A Bioequivalence Study of APX001 High-load and Low-load Tablets | ||
| NCT04166669 | A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 | ||
| NCT01813461 | Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects | ||
| NCT00229008 | Ceftobiprole in Hospital Acquired Pneumonia | ||
| NCT02059590 | A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects | ||
| NCT01809860 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects | ||
| NCT03241550 | A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients | ||
| NCT03230318 | Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma | ||
| NCT02128893 | A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole | ||
| NCT05582187 | A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function. | ||
| NCT01026740 | Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers | ||
| NCT01711489 | A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult Subjects | ||
| NCT06433128 | Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections | ||
| NCT04243863 | VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers | ||
| NCT05421858 | A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. | ||
| NCT02527681 | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics | ||
| NCT00210899 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | ||
| NCT00210964 | Ceftobiprole in Hospital Acquired Pneumonia | ||
| NCT04604132 | Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma | ||
| NCT01635972 | Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion | ||
| NCT02957929 | Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally | ||
| NCT01406171 | Drug Interaction Study of Isavuconazole and Midazolam | ||
| NCT05527834 | Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants | ||
| NCT01597986 | Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone | ||
| NCT01555866 | Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole. | ||
| NCT01660477 | Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole | ||
| NCT07500181 | A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects | ||
| NCT04314206 | VNRX-5024 Safety and PK in Healthy Adult Volunteers | ||
| NCT02895360 | Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma | ||
| NCT00519675 | Alitretinoin in the Treatment of Chronic Hand Eczema | ||
| NCT01026558 | A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients | ||
| NCT01651325 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects | ||
| NCT00529282 | A Study of Ceftobiprole in Patients With Fever and Neutropenia. | ||
| NCT04148287 | An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris |
